Stock-Based Compensation (Tables)

12 Months Ended

Jul. 31, 2026

The fair value of these awards was determined using the following inputs:

Option activity was as follows:


	Options	Weighted Average Exercise Price








Balance outstanding as of July 31, 2025	6,223,080	$	54.24
Granted	683,172	82.73
Exercised	(1,208,935)	46.58
Expired/forfeited	(29,352)	71.40
Balance outstanding as of July 31, 2026	5,667,965	$	59.22

Outstanding and exercisable stock options as of July 31, 2026 were as follows:


Range of Exercise Prices	Number Outstanding	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price		Number Exercisable	Weighted Average Remaining Contractual Life (Years)	Weighted Average Exercise Price
$42.26 to $46.99	1,190,976	2.5	$	45.07	1,190,976	2.5	$	45.07
$47.00 to $56.99	1,239,306	4.7	51.28		1,239,306	4.7	51.28
$57.00 to $66.99	1,809,367	5.2	59.51		1,559,803	4.9	59.45
$67.00 to $76.99	754,783	8.2	72.85		243,438	8.2	72.84
$77.00 and above	673,533	9.2	82.74		—	—	—
	5,667,965	5.4	$	59.22	4,233,523	4.4	$	53.79

For the year ended July 31, 2026, activity for non-vested stock options that contain vesting provisions was as follows:


	Options	Weighted Average Grant Date Fair Value
Balance outstanding as of beginning of year	1,575,041	$	19.73
Granted	683,172	25.86
Vested	(795,652)	18.57
Forfeited	(28,119)	22.16
Balance outstanding as of end of year	1,434,442	$	23.25

The weighted average grant date fair value related to the Company’s performance-based awards was as follows:


	Year Ended July 31,
	2026		2025		2024
Weighted average grant date fair value	$	82.70	$	73.18	$	59.66

Performance-based awards for non-vested activity were as follows:


	Performance Shares	Weighted Average Grant Date Fair Value
Balance outstanding as of July 31, 2025	197,684	$	66.19
Granted	107,800	82.70
Vested	(94,550)	59.66
Forfeited	(21,800)	69.69
Balance outstanding as of July 31, 2026	189,134	$	78.46